Related Experiment Videos
The Korean collaborative study on 11,000 prenatal genetic amniocentesis.
1Department of Obstetrics, Yonsei University College of Medicine, Seoul, Korea. ob@yumc.yonsei.ac.kr
Yonsei Medical Journal
|November 24, 1999
Summary
Amniocentesis use in Korea surged, shifting from primarily advanced maternal age to include abnormal serum markers and ultrasound findings. This prenatal diagnostic tool detected various chromosomal anomalies, including Down syndrome.
Area of Science:
- Obstetrics and Gynecology
- Medical Genetics
- Prenatal Diagnosis
Background:
- Amniocentesis, established in 1967, is a key prenatal diagnostic method.
- Its application in Korea has evolved significantly over time.
- Initial use was concentrated in advanced maternal age groups.
Purpose of the Study:
- To analyze trends in amniocentesis utilization in Korea from 1980 to 1997.
- To identify the changing indications for amniocentesis.
- To report the diagnostic yield of chromosomal anomalies.
Main Methods:
- Retrospective analysis of 11,000 amniocentesis procedures.
- Data collected from 10 Korean university hospitals and tertiary centers (1980-1997).
- Categorization of indications including maternal age, abnormal serum markers, and ultrasonographic findings.
Main Results:
- Amniocentesis use increased steadily, with a sharp rise in the mid-1990s.
- Indications shifted from advanced maternal age to abnormal serum markers (37.6% in 1995 to 44.8% in 1997).
- Chromosomal anomalies were detected in 2.5% of cases (270/11,000), including Down syndrome (96), Edward syndrome (33), Patau syndrome (6), Turner syndrome (10), and Klinefelter syndrome (10).
- Abnormal ultrasonographic findings led to chromosomal anomaly detection in 6.5% of cases (21/322).
Conclusions:
- Amniocentesis use in Korea has increased substantially, driven by new screening technologies.
- The diagnostic scope has broadened beyond maternal age to encompass biochemical and ultrasound markers.
- Genetic amniocentesis remains crucial for diagnosing chromosomal abnormalities in fetuses.